 |
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
Save the Date!
The Food and Drug Administration (FDA)
Small Business Regulatory Education for Industry (REdI) Conference
What: Fall REdI Conference
When: September 18-19, 2014
Where: Hyatt Regency Bethesda
1 Bethesda Metro Center
(7400 Wisconsin Avenue)
Bethesda, MD 20814
Registration is now open.
Please find conference information, registration information, and the agenda on our Conference webpage:
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm409987.htm
The Regulatory Education for Industry (REdI) Conference is an FDA-led forum that brings together the regulatory educators from FDA’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH). The goal of this conference is to provide direct, relevant, and helpful information on the key aspects of drug and device regulations. Our primary audience is that of small manufacturers of drug and/or device medical products who want to learn about how FDA approaches the regulation of drugs and devices.
Because the regulatory principles of drugs and devices are both similar and different, the REdI Conference features a cross-cutting plenary addressing issues which impact both drugs and devices, as well as individual break-out sessions which focus on the unique issues of drugs and devices.
Take advantage of this opportunity to interact with and learn directly from FDA experts.
Registration is FREE!
For more information on CDER SBIA
workshops and webinars visit
www.fda.gov/cdersbia
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info.
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
